AVIR vs IBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

AVIR

57.8
AI Score
VS
AVIR Wins

IBIO

45.7
AI Score

Investment Advisor Scores

AVIR

58score
Recommendation
HOLD

IBIO

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AVIR IBIO Winner
Revenue 159.19M 1.07M AVIR
Net Income 4.06M -7.55M AVIR
Net Margin 2.5% -702.4% AVIR
Operating Income 17.20M -8.34M AVIR
ROE 0.7% -9.6% AVIR
ROA 0.5% -8.5% AVIR
Total Assets 843.50M 88.65M AVIR
Cash 839.66M 45.44M AVIR
Current Ratio 3.22 9.48 IBIO

Relative Price Performance (Last 90 Days)

AVIR 1M: -15.3% · 3M: -16.8% IBIO 1M: +5.4% · 3M: -41.1%

Current Technical Phase

AVIR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.7%), weak momentum, RSI 43

RSI (14): 42.5 · Price: $4.22

IBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $0.82

Fundamentals Snapshot

Metric AVIR IBIO
Market Cap — —
Forward P/E -2.9 -2.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 3.0% -1.0%
Gross Margin -0.2% 1.0%
Operating Margin 0.0% -301.4%
EPS -1.95 -0.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AVIR is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.